Transdiagnostic-focused apps for depression and anxiety: a meta-analysis
Abstract Mental health apps that adopt a transdiagnostic approach to addressing depression and anxiety are emerging, yet a synthesis of their evidence-base is missing. This meta-analysis evaluated the efficacy of transdiagnostic-focused apps for depression and anxiety, and aimed to understand how th...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Digital Medicine |
| Online Access: | https://doi.org/10.1038/s41746-025-01860-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849235391905792000 |
|---|---|
| author | Jake Linardon Cleo Anderson Mariel Messer Claudia Liu John Torous |
| author_facet | Jake Linardon Cleo Anderson Mariel Messer Claudia Liu John Torous |
| author_sort | Jake Linardon |
| collection | DOAJ |
| description | Abstract Mental health apps that adopt a transdiagnostic approach to addressing depression and anxiety are emerging, yet a synthesis of their evidence-base is missing. This meta-analysis evaluated the efficacy of transdiagnostic-focused apps for depression and anxiety, and aimed to understand how they compare to diagnostic-specific apps. Nineteen randomized controlled trials (N = 5165) were included. Transdiagnostic-focused apps produced small post-intervention effects relative to controls on pooled outcomes related depression, anxiety and distress (N = 23 comparisons; g = 0.29; 95% CI = 0.17–0.40). Effects remained significant across various sensitivity analyses. CBT apps and apps that were compared with a waitlist produced larger effects. Significant effects were found at follow-up (g = 0.25; 95% CI = 0.10, 0.41). Effects were comparable to disorder-specific app estimates. Findings highlight the potential of transdiagnostic apps to provide accessible support for managing depression and anxiety. Their broad applicability highlights their public health relevance, especially when combined with in-person transdiagnostic therapies to create new hybrid care models. |
| format | Article |
| id | doaj-art-a73ed3d6932e46c68c8443908445f9fd |
| institution | Kabale University |
| issn | 2398-6352 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | npj Digital Medicine |
| spelling | doaj-art-a73ed3d6932e46c68c8443908445f9fd2025-08-20T04:02:46ZengNature Portfolionpj Digital Medicine2398-63522025-07-018111210.1038/s41746-025-01860-3Transdiagnostic-focused apps for depression and anxiety: a meta-analysisJake Linardon0Cleo Anderson1Mariel Messer2Claudia Liu3John Torous4SEED Lifespan Strategic Research Centre, School of Psychology, Faculty of Health, Deakin UniversitySEED Lifespan Strategic Research Centre, School of Psychology, Faculty of Health, Deakin UniversitySEED Lifespan Strategic Research Centre, School of Psychology, Faculty of Health, Deakin UniversitySEED Lifespan Strategic Research Centre, School of Psychology, Faculty of Health, Deakin UniversityDivision of Digital Psychiatry, Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical SchoolAbstract Mental health apps that adopt a transdiagnostic approach to addressing depression and anxiety are emerging, yet a synthesis of their evidence-base is missing. This meta-analysis evaluated the efficacy of transdiagnostic-focused apps for depression and anxiety, and aimed to understand how they compare to diagnostic-specific apps. Nineteen randomized controlled trials (N = 5165) were included. Transdiagnostic-focused apps produced small post-intervention effects relative to controls on pooled outcomes related depression, anxiety and distress (N = 23 comparisons; g = 0.29; 95% CI = 0.17–0.40). Effects remained significant across various sensitivity analyses. CBT apps and apps that were compared with a waitlist produced larger effects. Significant effects were found at follow-up (g = 0.25; 95% CI = 0.10, 0.41). Effects were comparable to disorder-specific app estimates. Findings highlight the potential of transdiagnostic apps to provide accessible support for managing depression and anxiety. Their broad applicability highlights their public health relevance, especially when combined with in-person transdiagnostic therapies to create new hybrid care models.https://doi.org/10.1038/s41746-025-01860-3 |
| spellingShingle | Jake Linardon Cleo Anderson Mariel Messer Claudia Liu John Torous Transdiagnostic-focused apps for depression and anxiety: a meta-analysis npj Digital Medicine |
| title | Transdiagnostic-focused apps for depression and anxiety: a meta-analysis |
| title_full | Transdiagnostic-focused apps for depression and anxiety: a meta-analysis |
| title_fullStr | Transdiagnostic-focused apps for depression and anxiety: a meta-analysis |
| title_full_unstemmed | Transdiagnostic-focused apps for depression and anxiety: a meta-analysis |
| title_short | Transdiagnostic-focused apps for depression and anxiety: a meta-analysis |
| title_sort | transdiagnostic focused apps for depression and anxiety a meta analysis |
| url | https://doi.org/10.1038/s41746-025-01860-3 |
| work_keys_str_mv | AT jakelinardon transdiagnosticfocusedappsfordepressionandanxietyametaanalysis AT cleoanderson transdiagnosticfocusedappsfordepressionandanxietyametaanalysis AT marielmesser transdiagnosticfocusedappsfordepressionandanxietyametaanalysis AT claudialiu transdiagnosticfocusedappsfordepressionandanxietyametaanalysis AT johntorous transdiagnosticfocusedappsfordepressionandanxietyametaanalysis |